1. Home
  2. IMVT vs PRIM Comparison

IMVT vs PRIM Comparison

Compare IMVT & PRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMVT
  • PRIM
  • Stock Information
  • Founded
  • IMVT N/A
  • PRIM 1960
  • Country
  • IMVT United States
  • PRIM United States
  • Employees
  • IMVT N/A
  • PRIM N/A
  • Industry
  • IMVT Biotechnology: Biological Products (No Diagnostic Substances)
  • PRIM Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • IMVT Health Care
  • PRIM Industrials
  • Exchange
  • IMVT Nasdaq
  • PRIM Nasdaq
  • Market Cap
  • IMVT 3.6B
  • PRIM 4.2B
  • IPO Year
  • IMVT N/A
  • PRIM N/A
  • Fundamental
  • Price
  • IMVT $21.27
  • PRIM $66.01
  • Analyst Decision
  • IMVT Strong Buy
  • PRIM Strong Buy
  • Analyst Count
  • IMVT 12
  • PRIM 6
  • Target Price
  • IMVT $45.90
  • PRIM $91.50
  • AVG Volume (30 Days)
  • IMVT 1.5M
  • PRIM 893.5K
  • Earning Date
  • IMVT 02-06-2025
  • PRIM 02-24-2025
  • Dividend Yield
  • IMVT N/A
  • PRIM 0.48%
  • EPS Growth
  • IMVT N/A
  • PRIM 26.31
  • EPS
  • IMVT N/A
  • PRIM 3.03
  • Revenue
  • IMVT N/A
  • PRIM $6,141,057,000.00
  • Revenue This Year
  • IMVT N/A
  • PRIM $11.33
  • Revenue Next Year
  • IMVT N/A
  • PRIM $5.26
  • P/E Ratio
  • IMVT N/A
  • PRIM $21.79
  • Revenue Growth
  • IMVT N/A
  • PRIM 11.07
  • 52 Week Low
  • IMVT $19.07
  • PRIM $37.00
  • 52 Week High
  • IMVT $39.55
  • PRIM $90.86
  • Technical
  • Relative Strength Index (RSI)
  • IMVT 47.11
  • PRIM 30.35
  • Support Level
  • IMVT $20.41
  • PRIM $73.23
  • Resistance Level
  • IMVT $21.43
  • PRIM $81.02
  • Average True Range (ATR)
  • IMVT 1.13
  • PRIM 3.14
  • MACD
  • IMVT 0.23
  • PRIM -1.09
  • Stochastic Oscillator
  • IMVT 54.52
  • PRIM 4.15

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).

About PRIM Primoris Services Corporation

Primoris Services Corp is a provider of infrastructure services operating mainly in the United States and Canada. It provides a wide range of construction services, maintenance, replacement, fabrication and engineering services to a diversified base of customers. The reportable segments are Utilities segment and the Energy segment. The Utilities segment operates in a range of services, including the installation and maintenance of new and existing natural gas and electric utility distribution and transmission systems, and communication systems. The Energy segment operates in a range of services that include engineering, procurement, and construction, retrofits, highway and bridge construction, demolition, site work, outages, pipeline construction and maintenance and others.

Share on Social Networks: